Schaeffer's Top Stock Picks for '25

Stocks Move Lower as Rate Cut Enthusiasm Fades

Investors are anxious to hear from Fed Chairman Jerome Powell

Digital Content Manager
Aug 22, 2024 at 11:40 AM
facebook X logo linkedin


The enthusiasm that followed the release of the Federal Reserve's meeting minutes is already fading. The Dow Jones Industrial Average (DJI) was last seen down nearly triple digits, while the S&P 500 Index (SPX) and Nasdaq Composite Index (IXIC) carry midday losses of their own. Wall Street is still hopeful for an interest cut in September, but investors are now anxiously awaiting Fed Chair Jerome Powell's incoming comments at the Jackson Hole Economic Symposium tomorrow.

Continue reading for more on today's market, including:

  • Unexpected sales growth boots Peloton stock.
  • Why this analyst upgraded Crocs stock to "buy."
  • Plus, SNOW brushes off quarterly win; BEN bounces off lows; and Moderna stock struggles.

MMC Stats 0822

Snowflake Inc (NYSE:SNOW) is seeing plenty of activity in the options pits today, with 117,000 calls and 93,000 puts traded so far -- 11 times the intraday average volume. The most active contract is the weekly 8/23 120-strike put, with new positions being opened there. SNOW is down 12% to trade at $118.89 at last check, despite the cloud concern beating earnings and revenue estimates for the second quarter. Analysts noted slowing growth and handed out no fewer than 12 price-target cuts, contributing to the security's 40.2% year-to-date deficit.

Franklin Resources Inc (NYSE:BEN) stock is leading the SPX today, up 3.2% to trade at $20.42 at last glance, as it bounces off its lowest level since October 2020. BEN's last rally failed to conquer the 80-day moving average, which rejected shares multiple times in July. The equity has shed 31.4% so far this year.
 

BEN 80 Day

Moderna Inc (NASDAQ:MRNA) is the worst stock on the SPX today, last seen down 3.3% to trade at $83.81. The shares are consolidating above the $80 level after slipping to their lowest level since December on the heels of multiple post-earnings bear gaps in late July. So far in 2024, the pharmaceutical stock has dropped more than 15%.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?

 

 

(function(doc, script) { var js, fjs = doc.getElementsByTagName(script)[0], frag = doc.createDocumentFragment(), add = function(url, id) { if (doc.getElementById(id)) {return;} js = doc.createElement(script); js.src = url; id && (js.id = id); frag.appendChild( js ); }; // Google+ button //add('https://apis.google.com/js/platform.js', async="defer"); // Facebook SDK add('//connect.facebook.net/en_US/all.js#xfbml=1&appId=772755279557744', 'facebook-jssdk'); // Twitter SDK //add('//platform.twitter.com/widgets.js', charset='utf-8'); fjs.parentNode.insertBefore(frag, fjs); }(document, 'script'));